TLCD3B and retinal degeneration: In a previous study (Qian et al., 2022), we performed gene therapy on Tlcd3b−/− mice and successfully rescued the retinal degeneration phenotypes by subretinally injecting a recombinant adeno-associated virus 8 (rAAV8) vector containing the Tlcd3b gene (rAAV8-Tlcd3b).